7/27/2020 7:33:24 AM
Ocugen Says Granted FDA Orphan Drug Designation For OCU400 Gene Therapy
6/1/2020 9:34:40 AM
Ocugen To Discontinue Phase 3 Trial Of OCU300 For Ocular Graft Vs. Host Disease
10/9/2019 7:34:45 AM
Ocugen Plans Repurchase Of Up To $2 Mln Of Common Stock